Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Potkin

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Psychiatry|January 6, 2012
Asenapine: a clinical overviewSteven G Potkin
International Psychogeriatrics|March 15, 2003
The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patientsSteven G Potkin
Journal of Clinical Psychopharmacology|May 6, 2008
New advances in the treatment of schizophrenia. IntroductionSteven G Potkin
Expert Opinion on Pharmacotherapy|February 12, 2016
Aripiprazole once-monthly long-acting injectable for the treatment of schizophreniaSteven G Potkin, Adrian Preda
Clinics in Geriatric Medicine|March 18, 2004
Alzheimer disease and other dementiasGustavo Alva, Steven G Potkin
British Medical Bulletin|May 20, 2008
Circadian abnormalities, molecular clock genes and chronobiological treatments in depressionJennifer N Bunney, Steven G Potkin
Future Neurology|February 26, 2019
New directions in therapeutics for Huntington diseaseKatya T Potkin, Steven G Potkin
The American Journal of Psychiatry|November 4, 2009
Dropouts and missing data in psychiatric clinical trialsSteven G Potkin, Cynthia O Siu
Schizophrenia Bulletin|November 22, 2008
Widespread cortical dysfunction in schizophrenia: the FBIRN imaging consortiumSteven G Potkin, Judith M Ford
The Journal of Clinical Psychiatry|October 27, 2007
Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trialSteven G Potkin, Miriam Cohen, John Panagides
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Psychiatry|January 6, 2012
Asenapine: a clinical overviewSteven G Potkin
International Psychogeriatrics|March 15, 2003
The ABC of Alzheimer's disease: ADL and improving day-to-day functioning of patientsSteven G Potkin
Journal of Clinical Psychopharmacology|May 6, 2008
New advances in the treatment of schizophrenia. IntroductionSteven G Potkin
Expert Opinion on Pharmacotherapy|February 12, 2016
Aripiprazole once-monthly long-acting injectable for the treatment of schizophreniaSteven G Potkin, Adrian Preda
Clinics in Geriatric Medicine|March 18, 2004
Alzheimer disease and other dementiasGustavo Alva, Steven G Potkin
British Medical Bulletin|May 20, 2008
Circadian abnormalities, molecular clock genes and chronobiological treatments in depressionJennifer N Bunney, Steven G Potkin
Future Neurology|February 26, 2019
New directions in therapeutics for Huntington diseaseKatya T Potkin, Steven G Potkin
The American Journal of Psychiatry|November 4, 2009
Dropouts and missing data in psychiatric clinical trialsSteven G Potkin, Cynthia O Siu
Schizophrenia Bulletin|November 22, 2008
Widespread cortical dysfunction in schizophrenia: the FBIRN imaging consortiumSteven G Potkin, Judith M Ford
The Journal of Clinical Psychiatry|October 27, 2007
Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trialSteven G Potkin, Miriam Cohen, John Panagides
Pageof 22